Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
作者:Yan A. Ivanenkov、Sergei V. Vasilevski、Elena K. Beloglazkina、Maksim E. Kukushkin、Alexey E. Machulkin、Mark S. Veselov、Nina V. Chufarova、Elizaveta S. Chernyaginab、Anton S. Vanzcool、Nikolay V. Zyk、Dmitry A. Skvortsov、Anastasia A. Khutornenko、Alexander L. Rusanov、Alexander G. Tonevitsky、Olga A. Dontsova、Alexander G. Majouga
DOI:10.1016/j.bmcl.2014.09.070
日期:2015.1
Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics.
一系列新的非对映异构体2-thioxo-5 H -dispiro [imidazolidine-4,3-pyrrolidine-2,3-indole] -2,5(1 H)-diones的区域选择性合成,生物学评估和3D分子建模是描述。暂时将研究的化合物鉴定为有效的小分子MDM2 / p53 PPI抑制剂,因此可以合理地视为有前途的抗癌治疗剂。